查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区非侵入性产前检测 (NIPT) 市场：按测试方法、按平台、按最终用户、按应用、按国家/地区 - 分析和预测 (2023-2033)
市场调查报告书
商品编码
1599902

亚太地区非侵入性产前检测 (NIPT) 市场：按测试方法、按平台、按最终用户、按应用、按国家/地区 - 分析和预测 (2023-2033)

Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 68 Pages | 商品交期: 1-5个工作天内

价格

2023年，亚太地区非侵入性产前检测（NIPT）市场规模达6.592亿美元。

预计到 2033 年，该市场将达到 27.673 亿美元，2023-2033 年预测期间复合年增长率为 15.43%。支持性医疗保健政策的采用、筛检测试保险覆盖范围的扩大、技术的持续进步、整个全部区域机会的扩大以及准妈妈和医疗保健提供者对非侵入性检测方法的日益偏好是推动亚太地区非侵入性检测的关键因素。

主要市场统计数据
预测期 2023-2033
2023年评估 6.592 亿美元
2033 年预测 27.673 亿美元
复合年增长率 15.43%

由于该地区医疗保健支出的增加以及对复杂产前筛检技术的了解不断增长，亚太地区无创产前检测 (NIPT) 市场正在显着扩张。由于其准确性、安全性和非侵入性，NIPT 作为一项用于检查母血中胎儿游离 DNA 的突破性技术而变得越来越受欢迎。它在怀孕期间经常用于识别染色体异常，例如帕陶综合症、爱德华兹综合症和唐氏症。

母亲年龄的老化、先进遗传技术的可用性以及准确及时的产前诊断的需求正在推动市场成长。许多亚太国家产前检测保险覆盖范围的扩大和医疗保健改革的实施进一步支持了 NIPT 的采用。

市场上的主要企业专注于开发负担得起的测试解决方案，以服务该地区不同的人口和广泛的收入水平。国际公司和当地医疗保健提供者之间的伙伴关係正在提高人们的意识和可及性，特别是在开发中国家。

该报告调查了亚太地区无创产前检测 (NIPT) 市场，按测试方法、平台、最终用户、应用、国家和市场参与者提供了市场概况，并提供了公司概况、 ETC。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 研究发展回顾
  • 监管状况
  • 赎回场景
  • 市场动态概览

第二章 区域

  • 促进因素和抑制因素
  • 区域概况
  • 亚太地区

第三章市场－竞争基准化分析与公司概况

  • 竞争格局
    • BGI Genomics
    • Annoroad Gene Technology

第四章调查方法

Product Code: BHL2407SS

Introduction to Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market

The Asia-Pacific NIPT market was valued at $659.2 million in 2023 and is expected to reach $2,767.3 million by 2033, registering a CAGR of 15.43% during the forecast period 2023-2033. The adoption of supportive healthcare policies, the growing inclusion of screening procedures in insurance coverage, ongoing technological advancements, the expansion of commercial opportunities throughout the region, and the growing preference for non-invasive testing methods among expectant parents and healthcare providers are the main factors propelling the APAC NIPT market.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$659.2 Million
2033 Forecast$2,767.3 Million
CAGR15.43%

The market for non-invasive prenatal testing (NIPT) in Asia-Pacific is expanding significantly due to increased healthcare spending in the region and growing knowledge of sophisticated prenatal screening techniques. Because of its great accuracy, safety, and non-invasiveness, NIPT-a ground-breaking technology that examines cell-free fetal DNA from maternal blood-is becoming more and more popular. During pregnancy, it is frequently used to identify chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome.

Growing maternal age, the use of sophisticated genetic technologies, and the need for accurate and timely prenatal diagnostics are driving the market's growth. The adoption of NIPT is being further supported by the expansion of insurance coverage for prenatal care and the implementation of healthcare reforms in many Asia-Pacific nations.

The market's major players are concentrating on creating affordable testing solutions to serve the region's diverse population and range of income levels. Partnerships between international corporations and regional healthcare providers are increasing awareness and accessibility, especially in developing nations.

As prenatal health awareness rises and healthcare infrastructure improves, the APAC NIPT market is expected to grow rapidly. It will be crucial in improving maternal and fetal health outcomes throughout the area.

Market Segmentation:

Segmentation 1: by Application

  • Trisomy Detection
  • Microdeletion Detection
  • Sex Chromosome Aneuploidy Detection
  • Others

Segmentation 2: by End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

Segmentation 3: by Platform

  • NGS
  • PCR
  • Others

Segmentation 4: by Method

  • cfDNA
  • FCMB

Segmentation 5: by Country

  • China
  • India
  • Japan
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • BGI Genomics
  • Annoroad Gene Technology

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
    • 1.1.2 Expanding Applications in NIPT Products
  • 1.2 Supply Chain Overview
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
    • 1.4.1 Regulatory Scenario in China
    • 1.4.2 Regulatory Scenario in India
    • 1.4.3 Regulatory Scenario in Australia
    • 1.4.4 Regulatory Scenario in Japan
  • 1.5 Reimbursement Scenario
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 High Incidence of Genetic Disorders
      • 1.6.1.2 Rising Maternal Age
      • 1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
      • 1.6.1.4 Increased Emphasis on Early Detection and Prevention
    • 1.6.2 Market Restraints
      • 1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
      • 1.6.2.2 Lack of Awareness Regarding NIPT
      • 1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia
      • 1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)

2 Regions

  • 2.1 Drivers and Restraints
  • 2.2 Regional Summary
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 China
    • 2.3.7 India
    • 2.3.8 Japan
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 BGI Genomics
      • 3.1.1.1 Overview
      • 3.1.1.2 Product Portfolio
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers
      • 3.1.1.5 Key Personnel
      • 3.1.1.6 Analyst View
    • 3.1.2 Annoroad Gene Technology
      • 3.1.2.1 Overview
      • 3.1.2.2 Product Portfolio
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers
      • 3.1.2.5 Key Personnel
      • 3.1.2.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 2: Asia-pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
  • Figure 5: Non-Invasive Prenatal Testing Market, Recent Developments, 2023
  • Figure 6: Supply Chain of NIPT Market
  • Figure 7: NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
  • Figure 8: NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
  • Figure 9: Reimbursement Scenario in Major Countries of the NIPT Market
  • Figure 10: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 11: Age of Mother at Childbirth over the Years
  • Figure 12: Reimbursement Scenario in Major Countries
  • Figure 13: Number of Tests Processed by Natera, Inc., 2018-2020
  • Figure 14: Positives from Data of 75,000 NIPT Tests Showing False Positives
  • Figure 15: Recent Developments in APAC by Key Companies
  • Figure 16: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 17: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033
  • Figure 18: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033
  • Figure 19: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 20: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 21: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 22: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 23: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 26: Share of Strategic Initiatives
  • Figure 27: Data Triangulation
  • Figure 28: Top-Down and Bottom-Up
  • Figure 29: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Non-Invasive Prenatal Testing Market, Opportunities
  • Table 3: Key Companies' Partnerships and Alliances
  • Table 4: NIPT Tests in the NIPT Market and their Corresponding Applications
  • Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age
  • Table 6: Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
  • Table 7: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
  • Table 8: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 9: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 10: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 11: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 12: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 13: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 14: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 15: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 16: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 17: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 18: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 19: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 20: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 21: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 22: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 23: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 26: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 27: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 28: Market Share (2022)